303 related articles for article (PubMed ID: 23348500)
1. A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signaling.
Noetzel MJ; Gregory KJ; Vinson PN; Manka JT; Stauffer SR; Lindsley CW; Niswender CM; Xiang Z; Conn PJ
Mol Pharmacol; 2013 Apr; 83(4):835-47. PubMed ID: 23348500
[TBL] [Abstract][Full Text] [Related]
2. Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.
Butkiewicz M; Rodriguez AL; Rainey SE; Wieting J; Luscombe VB; Stauffer SR; Lindsley CW; Conn PJ; Meiler J
ACS Chem Neurosci; 2019 Aug; 10(8):3427-3436. PubMed ID: 31132237
[TBL] [Abstract][Full Text] [Related]
3. N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
Chen Y; Goudet C; Pin JP; Conn PJ
Mol Pharmacol; 2008 Mar; 73(3):909-18. PubMed ID: 18056795
[TBL] [Abstract][Full Text] [Related]
4. Effects of positive allosteric modulators on single-cell oscillatory Ca2+ signaling initiated by the type 5 metabotropic glutamate receptor.
Bradley SJ; Watson JM; Challiss RA
Mol Pharmacol; 2009 Dec; 76(6):1302-13. PubMed ID: 19737913
[TBL] [Abstract][Full Text] [Related]
5. A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain.
O'Brien JA; Lemaire W; Wittmann M; Jacobson MA; Ha SN; Wisnoski DD; Lindsley CW; Schaffhauser HJ; Rowe B; Sur C; Duggan ME; Pettibone DJ; Conn PJ; Williams DL
J Pharmacol Exp Ther; 2004 May; 309(2):568-77. PubMed ID: 14747613
[TBL] [Abstract][Full Text] [Related]
6. Positive Allosteric Modulators of Metabotropic Glutamate Receptor 5 as Tool Compounds to Study Signaling Bias.
Arsova A; Møller TC; Hellyer SD; Vedel L; Foster SR; Hansen JL; Bräuner-Osborne H; Gregory KJ
Mol Pharmacol; 2021 May; 99(5):328-341. PubMed ID: 33602724
[TBL] [Abstract][Full Text] [Related]
7. Development of allosteric modulators of GPCRs for treatment of CNS disorders.
Nickols HH; Conn PJ
Neurobiol Dis; 2014 Jan; 61():55-71. PubMed ID: 24076101
[TBL] [Abstract][Full Text] [Related]
8. Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses.
Chen Y; Nong Y; Goudet C; Hemstapat K; de Paulis T; Pin JP; Conn PJ
Mol Pharmacol; 2007 May; 71(5):1389-98. PubMed ID: 17303702
[TBL] [Abstract][Full Text] [Related]
9. The effect of mGlu5 receptor positive allosteric modulators on signaling molecules in brain slices.
Liu F; Zhang G; Hornby G; Vasylyev D; Bowlby M; Park K; Gilbert A; Marquis K; Andree TH
Eur J Pharmacol; 2006 May; 536(3):262-8. PubMed ID: 16600209
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation of a novel positive allosteric modulator of metabotropic glutamate receptor subtype 5 contributes to seizure-like adverse events in rats involving a receptor agonism-dependent mechanism.
Bridges TM; Rook JM; Noetzel MJ; Morrison RD; Zhou Y; Gogliotti RD; Vinson PN; Xiang Z; Jones CK; Niswender CM; Lindsley CW; Stauffer SR; Conn PJ; Daniels JS
Drug Metab Dispos; 2013 Sep; 41(9):1703-14. PubMed ID: 23821185
[TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamate receptor 5 (mGlu
Hellyer SD; Albold S; Sengmany K; Singh J; Leach K; Gregory KJ
J Neurochem; 2019 Nov; 151(3):301-315. PubMed ID: 31376155
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity.
Rodriguez AL; Grier MD; Jones CK; Herman EJ; Kane AS; Smith RL; Williams R; Zhou Y; Marlo JE; Days EL; Blatt TN; Jadhav S; Menon UN; Vinson PN; Rook JM; Stauffer SR; Niswender CM; Lindsley CW; Weaver CD; Conn PJ
Mol Pharmacol; 2010 Dec; 78(6):1105-23. PubMed ID: 20923853
[TBL] [Abstract][Full Text] [Related]
13. A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators.
Rodriguez AL; Nong Y; Sekaran NK; Alagille D; Tamagnan GD; Conn PJ
Mol Pharmacol; 2005 Dec; 68(6):1793-802. PubMed ID: 16155210
[TBL] [Abstract][Full Text] [Related]
14. Progress toward positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5).
Stauffer SR
ACS Chem Neurosci; 2011 Aug; 2(8):450-70. PubMed ID: 22860171
[TBL] [Abstract][Full Text] [Related]
15. ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities.
Liu F; Grauer S; Kelley C; Navarra R; Graf R; Zhang G; Atkinson PJ; Popiolek M; Wantuch C; Khawaja X; Smith D; Olsen M; Kouranova E; Lai M; Pruthi F; Pulicicchio C; Day M; Gilbert A; Pausch MH; Brandon NJ; Beyer CE; Comery TA; Logue S; Rosenzweig-Lipson S; Marquis KL
J Pharmacol Exp Ther; 2008 Dec; 327(3):827-39. PubMed ID: 18753411
[TBL] [Abstract][Full Text] [Related]
16. Unique signaling profiles of positive allosteric modulators of metabotropic glutamate receptor subtype 5 determine differences in in vivo activity.
Rook JM; Noetzel MJ; Pouliot WA; Bridges TM; Vinson PN; Cho HP; Zhou Y; Gogliotti RD; Manka JT; Gregory KJ; Stauffer SR; Dudek FE; Xiang Z; Niswender CM; Daniels JS; Jones CK; Lindsley CW; Conn PJ
Biol Psychiatry; 2013 Mar; 73(6):501-9. PubMed ID: 23140665
[TBL] [Abstract][Full Text] [Related]
17. Exploration of allosteric agonism structure-activity relationships within an acetylene series of metabotropic glutamate receptor 5 (mGlu5) positive allosteric modulators (PAMs): discovery of 5-((3-fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254).
Turlington M; Noetzel MJ; Chun A; Zhou Y; Gogliotti RD; Nguyen ED; Gregory KJ; Vinson PN; Rook JM; Gogi KK; Xiang Z; Bridges TM; Daniels JS; Jones C; Niswender CM; Meiler J; Conn PJ; Lindsley CW; Stauffer SR
J Med Chem; 2013 Oct; 56(20):7976-96. PubMed ID: 24050755
[TBL] [Abstract][Full Text] [Related]
18. Allosteric potentiators of metabotropic glutamate receptor subtype 5 have differential effects on different signaling pathways in cortical astrocytes.
Zhang Y; Rodriguez AL; Conn PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1212-9. PubMed ID: 16135701
[TBL] [Abstract][Full Text] [Related]
19. Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHA.
Zhao Z; Wisnoski DD; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Wittman M; Ha SN; Schaffhauser H; Sur C; Pettibone DJ; Duggan ME; Conn PJ; Hartman GD; Lindsley CW
Bioorg Med Chem Lett; 2007 Mar; 17(5):1386-91. PubMed ID: 17210250
[TBL] [Abstract][Full Text] [Related]
20. Biased mGlu5-Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu5 Modulation of NMDAR Currents.
Rook JM; Xiang Z; Lv X; Ghoshal A; Dickerson JW; Bridges TM; Johnson KA; Foster DJ; Gregory KJ; Vinson PN; Thompson AD; Byun N; Collier RL; Bubser M; Nedelcovych MT; Gould RW; Stauffer SR; Daniels JS; Niswender CM; Lavreysen H; Mackie C; Conde-Ceide S; Alcazar J; Bartolomé-Nebreda JM; Macdonald GJ; Talpos JC; Steckler T; Jones CK; Lindsley CW; Conn PJ
Neuron; 2015 May; 86(4):1029-1040. PubMed ID: 25937172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
